Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Levofloxacin - Daiichi Sankyo

Next Previous
X
Search
Drug Profile

Levofloxacin - Daiichi Sankyo

Alternative Names: Cravit Intravenous; Cravit Oral; DR-3355; Levaquin; Levaquin Oral Solution; Tavanic

Latest Information Update: 05 Nov 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Daiichi Sankyo Company
  • Class Anti-infectives; Antibacterials; Fluoroquinolones; Small molecules
  • Mechanism of Action DNA gyrase inhibitors; Type II DNA topoisomerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Acute exacerbations of chronic bronchitis; Acute sinusitis; Anthrax; Bacterial infections; Community-acquired pneumonia; Gynaecological infections; Nosocomial pneumonia; Pneumonia; Postoperative infections; Prostatitis; Pyelonephritis; Respiratory tract infections; Sinusitis; Skin and soft tissue infections; Tuberculosis; Urinary tract infections

Most Recent Events

  • 26 Jul 2016 The US FDA approved label for levofloxacin carries a boxed warning
  • 24 Sep 2015 Registered for Urinary tract infections, Postoperative infections and gynaecological infections in Japan (IV)
  • 24 Aug 2015 Registered for Tuberculosis in Japan (PO)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top